Morepen Laboratories Ltd.
Fundamentals
- Market cap
- ₹2,913 cr
- P/E
- 30.70×
- ROE
- 10.21%
- Debt / equity
- 0.07
- Div yield
- 0.38%
- 52-week range
- 33.05 — 66.40
Morepen Laboratories Ltd.
Latest quarter · Mar 2026
Strength & growth
The timeline — 6 notes on Morepen Laboratories Ltd.
May 2026
- 27 May 26 · 8:26 AM IST Brief Brief · Earnings · Small cap
Morepen Laboratories profit jumps 69% as CDMO production kicks off
The company reported a net profit of ₹20 crore for Q4 FY26, supported by a 31% expansion in its medical devices division and new manufacturing output.
- 26 May 26 · 6:49 PM IST Brief Brief · Earnings · Small cap
Morepen Laboratories profit drops 20% as margins tighten
Consolidated net profit fell to ₹94.88 crore on flat revenue of ₹1,805.69 crore for FY26. The board declared a final dividend of ₹0.20 per share.
- 26 May 26 · 5:58 PM IST Brief Brief · Earnings · Small cap
Morepen Laboratories reports 20% profit decline for FY26
Consolidated net profit dropped to ₹94.88 crore as revenue remained flat. The company also pushed the effective date for its medical devices business transfer to April 1, 2026.
- 26 May 26 · 5:38 PM IST Brief Brief · Earnings · Small cap
Morepen Laboratories profit drops 20% on flat revenue
Consolidated net profit fell to ₹94.88 crore for FY26 as margin pressure weighed on the bottom line. The board recommended a dividend of ₹0.20 per share.
- 20 May 26 · 7:11 PM IST Brief Brief · Small cap
Morepen locks in medical devices chief with subsidiary shares
The company transferred 1,62,000 shares of Morepen Medipath to Anubhav Suri, reducing its stake from 60% to 51% while retaining control. No price was disclosed.